Assessment of the efficacy of treatment of recurrent gliomas and brain metastases using a novel advanced diffusion sequence in MRI

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300067461

Enrollment

Unknown

Registered

2023-01-09

Start date

2023-02-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Glioma, Brain metastasis

Interventions

recurrent glioma group:Nil

Brain metastasis Group:Nil

Eligibility

Sex/Gender

All

Age

1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1 Previous history of glioma treated by surgical resection and new intracranial masses found during imaging follow-up. 2 Previous history of extracranial primary tumour with new, multiple intracranial foci presenting during imaging follow-up.

Exclusion criteria

Exclusion criteria: 1 Patients with contraindications to MRI scanning such as claustrophobia or pacemaker implantation 2 The patient did not cooperate well and there were significant artefacts in the MRI images from the scan.

Design outcomes

Primary

Measure	Time frame
cell diameter,d;intracellular volume fraction,Vin;intracellular diffusion coefficient,Din;extracellular diffusion coefficient,Dex;	—

Countries

China

Contacts

Public ContactJiaji Mao

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

maojj6@mail.sysu.edu.cn13570978338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026